References
- Bakheit, A. M., Kennedy, P. G., & Behan, P. O. (1990). Paraneoplastic limbic encephalitis: Clinico-pathological correlations. Journal of Neurology, Neurosurgery & Psychiatry, 53(12), 1084–1088. doi:10.1136/jnnp.53.12.1084.
- Consoli, A., Ronen, R., An-Gourfinkel, I., Barbeau, M., Marra, D., Costedoat-Chalumeau, N., Montefiore, D., Maksud, P., Bonnot, O., Didelot, A., Amoura, Z., Vidailhet, M., & Cohen, D. (2011). Malignant catatonia due to anti-NMDA-receptor encephalitis in a 17 year old: Case report. Child and Adolescent Psychiatry & Mental Health, 5, 1.
- Dalmau, J., Lancaster, E., Martinez-Hernandez, E., et al. (2011). Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurology, 10(1), 47–63.
- Dalmau, J., & Rosenfeld, M. R. (2008). Paraneoplastic syndromes of the CNS. The Lancet Neurology, 7(4), 327–340.
- Finke, C., Kopp, U. A., Pruss, H., Dalmau, J., Wandinger, K. P., & Ploner, C. J. (2012). Cognitive deficits following anti-NMDA receptor encephalitis. Journal of Neurology, Neurosurgery & Psychiatry, 83, 195–198.
- Graus, F., Saiz, A., Lai, M., Bruna, J., Lo´pez, F., Sabater, L., Blanco, Y., Rey, M. J., Ribalta, T., & Dalmau, J. (2008). Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunological associations, Neurology, 71, 930–936.
- Gultekin, S. H., Rosenfeld, M. R., Voltz, R., Eichen, J., Posner, J. B., & Dalmau, J. (2000). Paraneoplastic limbic encephalitis: Neurological symptoms, immunological findings and tumour association in 50 patients. Brain, 123(7), 1481–1494.
- Irani, S. R., & Vincent, A. (2001). Autoimmune encephalitis-new awareness, challenging questions. Discovery Medicine, 11, 449–458.
- Jammoul, A., Li, Y., & Rae-Grant, A. (2016). Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable. Cleveland Clinic Journal of Medicine, 83(1): 43–53.
- Kuppuswamy, P. S., Takala, C. R., & Sola, C. L. (2014). Management of psychiatric symptoms in anti-NMDAR encephalitis: A case series, literature review and future directions. General 15 Hospital Psychiatry, 36, 388–391.
- Leypoldt, F., Titulaer, M. J., Aguilar, E., Walther, J., et al. (2013). Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis, case report. Neurology, 81(18), 1637–9.
- Loughan, A. R., Allen, A., Perna, R., & Malkin, M. G. (2016). Anti-N-Methyl-D-aspartate receptor encephalitis: A review and neuropsychological case study. The Clinical Neuropsychologist, 30(1), 150–163.
- Maneta, E., & Garcia, G. (2014). Psychiatric manifestations of Anti-NMDA receptor encephalitis: Neurobiological underpinnings and differential diagnostic implications. Psychosomatics, 55, 37–44.
- Peery, H., Day, G. S., Dunn, S., et al. (2012). Anti-NMDA receptor encephalitis: The disorder, the diagnosis and immunobiology. Autoimmune Review, 11, 863–872.
- Sands, T. T., Nash, K., Tong, S., & Sullivan, J. (2015). Focal seizures in children with anti-NMDA receptor antibody encephalitis. Epilepsy Research, 112, 31–36.
- Titulaer, M. J., McCracken, L., Gabilondo, I., Glaser, C., et al. (2013). Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study. Lancet Neurology, 12(2), 157–165.
- Titulaer, M. J., & Dalmau, J. (2014). Seizures as first symptom of anti-NMDA receptor encephalitis are more common in men. Neurology, 82(7), 550–551.
- Tüzün, E., & Dalmau, J. (2007). Limbic encephalitis and variants: Classification, diagnosis and treatment. The Neurologist, 13(5), 261–271.